Suppression of ABCA1 by unsaturated fatty acids leads to lipid accumulation in HepG2 cells

Biochimie

Volumn 92, Issue 8, 2010, Pages 958-963

  Yang, Yanhong ^a   Jiang, Ying ^a   Wang, Yutong ^a   An, Wei ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

ATP binding cassette transporter; Fatty acid; NASH; Protein degradation

Indexed keywords

ABC TRANSPORTER A1; CHOLESTEROL; FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; SMALL INTERFERING RNA; TRIACYLGLYCEROL; UNSATURATED FATTY ACID;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL STRAIN HEPG2; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ENZYME REPRESSION; FATTY LIVER; GENE OVEREXPRESSION; GENE REPRESSION; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER CELL; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN DEGRADATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; CELL LINE; CRICETINAE; DNA PRIMERS; FATTY ACIDS, UNSATURATED; HUMANS; LIPID METABOLISM; RATS;

CRICETINAE; MURINAE; RATTUS;

EID: 77954659321     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.04.002     Document Type: Article

References (41)

1. Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., McCullough A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116:1413-1419.
2. Okamoto M., Takeda Y., Yoda Y., Kobayashi K., Fujino M.A., Yamagata Z. The association of fatty liver and diabetes risk. J. Epidemiol 2003, 13:15-21.
3. Hamaguchi M., Kojima T., Takeda N., Nakagawa T., Taniguchi H., Fujii K., Omatsu T., Nakajima T., Sarui H., Shimazaki M., Kato T., Okuda J., Ida K. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med 2005, 143:722-728.
4. Ludwig J., Viggiano T.R., McGill D.B., Oh B.J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin. Proc. 1980, 55:434-438.
5. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y.C., Torbenson M.S., Unalp-Arida A., Yeh M., McCullough A.J., Sanyal A.J. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
6. Day C.P., James O.F.W. Steatohepatitis: a tale of two " hits" Gastroenterology 1998, 114:842-845.
7. Youssef W., McCullough A.J. Diabetes mellitus, obesity, and hepatic steatosis. Semin. Gastrointest. Dis 2002, (1):17-30.
8. Kremer M., Thomas E., Milton R.J., Perry A.W., van Rooijen N., Wheeler M.D., Zacks S., Fried M., Rippe R.A., Hines I.N. Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis. Hepatology 2010, 51:130-141.
9. Ma X., Hua J., Mohamood A.R., Hamad A.R., Ravi R., Li Z. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology 2007, 46:1519-1529.
10. Musso G., Gambino R., Cassader M. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders. Curr. Opin. Lipidol 2010, 21:76-83.
11. Sheth S.G., Gordon F.D., Chopra S. Non alcoholic steatohepatitis. Ann. Intern. Med 1997, 126:137-145.
12. Joyce C., Freeman L., Brewer H.B., Santamarina-Fojo S. Study of ABCA1 function in transgenic mice. Arterioscler. Thromb. Vasc. Biol. 2003, 23:965-971.
13. Aiello R.J., Brees D., Francone O.L. ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation. Arterioscler. Thromb. Vasc. Biol. 2003, 23:972-980.
14. Oram J.F., Heinecke J.W. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol. Rev. 2005, 85:1343-1372.
15. Wang N., Tall A.R. Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1178-1184.
16. Lawn R.M., Wade D.P., Garvin M.R., Wang X., Schwartz K., Porter J.G., Seilhamer J.J., Vaughan A.M., Oram J.F. The Tangier disease gene product ABCA1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest 1999, 104:R25-R31.
17. Langmann T., Klucken J., Reil M., Liebisch G., Luciani M.F., Chimini G., Kaminski W.E., Schmitz G. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun 1999, 257:29-33.
18. Schwartz K., Lawn R.M., Wade D.P. ABCA1 gene expression and apoA-I-mediated cholesterol efflux are regulated by LXR. Biochem. Biophys. Res. Commun 2000, 274:794-802.
19. Costet P., Luo Y., Wang N., Tall A.R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 2000, 275:28240-28245.
20. Venkateswaran A., Laffitte B.A., Joseph S.B., Mak P.A., Wilpitz D.C., Edwards P.A., Tontonoz P. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc. Natl. Acad. Sci. USA 2000, 97:12097-12102.
21. Martinez L.O., Agerholm-Larsen B., Wang N., Chen W., Tall A.R. Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J. Biol. Chem. 2003, 278:37368-37374.
22. Yamauchi Y., Hayashi M., Abe-Dohmae S., Yokoyama S. Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly. J. Biol. Chem. 2003, 278:47890-47897.
23. See R.H., Candy-Malcolm R.A., Singaraja R.R., Zhou S., Silverston A., Huber M.T., Moran J., James E.R., Janoo R., Savill J.M., et al. Protein kinase A site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux. J. Biol. Chem. 2002, 277:41835-41842.
24. Roosbeek S., Peelman F., Verhee A., Labeur C., Caster H., Lensink M.F., Cirulli C., Grooten J., Cochet C., Vandekerckhove J., et al. Phosphorylation by protein kinase CK2 modulates the activity of the ATP binding cassette A1 transporter. J. Biol. Chem. 2004, 279:37779-37788.
25. Tang C., Vaughan A.M., Oram J.F. Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol. J. Biol. Chem. 2004, 279:7622-7628.
26. Wang Y., Oram J.F. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette A1. J. Biol. Chem. 2002, 277:5692-5697.
27. Wang Y., Oram J.F. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. J. Biol. Chem. 2005, 280:35896-35903.
28. Wang Y., Oram J.F. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C δ pathway. J. Lipid Res. 2007, 48:1062-1068.
29. Jiang Y., Zhang H., Dong L.Y., Wang D., An W. Increased hepatic UCP2 expression in rats with nonalcoholic steatohepatitis is associated with upregulation of Sp1 binding to its motif within the proximal promoter region. J. Cell. Biochem 2008, 105:277-289.
30. Oram J.F., Lawn R.M., Garvin M.R., Wade D.P. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 2000, 275:34508-34511.
31. Abe-Dohmae S., Suzuki S., Wada Y., Aburatani H., Vance D.E., Yokoyama S. Characterization of apolipoprotein-mediated HDL generation induced by cAMP in a murine macrophage cell line. Biochemist 2000, 39:11092-11099.
32. Cignarella A., Engel T., von Eckardstein A., Kratz M., Lorkowski S., Lueken A., Assmann G., Cullen P. Pharmacological regulation of cholesterol efflux in human monocyte-derived macrophages in the absence of exogenous cholesterol acceptors. Atherosclerosis 2005, 179:229-236.
33. Li C., Kong Y., Wang H., Wang S., Yu H., Liu X., Yang L., Jiang X., Li L., Li L. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J. Hepatol 2009, 50:1174-1183.
34. Wang Y., Kurdi-Haidar B., Oram J.F. LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1. J. Lipid Res 2004, 45:972-980.
35. Bierman E.L. George Lyman Duff Memorial Lecture, Atherogenesis in diabetes. Arterioscler. Thromb 1992, 12:647-656.
36. Ginsberg H.N. Lipoprotein physiology in nondiabetic and diabetic states, Relationship to atherogenesis. Diabetes Care 1991, 14:839-855.
37. Farrell G.C., Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006, 43:S99-112.
38. Senanayake S., Brownrigg L.M., Panicker V., Croft K.D., Joyce D.A., Steer J.H., Puddey I.B., Yeap B.B. Monocyte-derived macrophages from men and women with Type 2 diabetes mellitus differ in fatty acid composition compared with non-diabetic controls. Diabetes Res. Clin. Pract 2007, 75:292-300.
39. Hu F.B., Stampfer M.J., Manson J.E., Rimm E., Colditz G.A., Rosner B.A., Hennekens C.H., Willett W.C. Dietary fat intake and the risk of coronary heart disease in women. N. Engl. J. Med 1997, 337:1491-1499.
40. Gentile C.L., Pagliassotti M.J. The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. J. Nutr. Biochem 2008, 19:567-576.
41. Sheril A., Jeyakumar S.M., Jayashree T., Giridharan N.V., Vajreswari A. Impact of feeding polyunsaturated fatty acids on cholesterol metabolism of dyslipidemic obese rats of WNIN/GR-Ob strain. Atherosclerosis 2009, 204:136-140.